NCT05605704RecruitingPhase 2/3
Olive Leaf Extracts in the Control of Diabet
Efficacy of a Treatment Based on Olive Leaf Extracts in the Control of Diabet
Source: ClinicalTrials.gov · Last updated 3 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 22 Sept 2022
- Start date
- 1 Jan 2023
- Primary completion date
- 15 Sept 2025
- Lead sponsor
- University of Monastir
- Diseases
- Type 2 diabetes
- NCT number
- NCT05605704
What you commit to
- Study type: Interventional · Phase 2/3
- Planned participants: 500
- From 1 Jan 2023 to the primary completion date, 15 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Exclusion criteria: None.
Who the study is looking for
- Patients over 18 years of age with:
- diabetes.
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Semir Nouira Coordinator of this site? Confirm its status | Monastir | Tunisia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.